Ongoing industry-sponsored Phase III (including II/III) and pivotal Phase II HRPC trials. Excludes trials focused on biosimilars, generics, supportive care, metastases (to brain, bone, etc.) and trials that began prior to January 1, 2013.

Trialscape is a powerful visual analysis tool derived from the comprehensive clinical trials intelligence in Citeline’s Trialtrove. Each Trialscape map displays the current and future competitive landscape of pharmaceutical clinical trials in a specific area of research. The Trialscape solution provides graphical representation of pharmaceutical clinical trial timelines in support of strategic decisions in drug development, clinical operations and marketing.